Edap Tms Sa ADR (FOCL) Stock Price, Quote & News

Company Profile

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and...

Industry: Medical Distribution

Sector: Healthcare

Phone: 33 4 72 15 31 50

Website: investor.focalone.com

Address:

Parc d’Activites la Poudrette-Lamartine, 4/6, rue du Dauphiné, Vaulx-en-Velin, France

Georges8792 Jun. 25 at 2:39 AM

$FOCL https://www.linkedin.com/posts/masterclass-exclusiva-aplicaci%C3%B3n-cl%C3%ADnica-share-7475192073839849472-mu0l/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Georges8792 Jun. 25 at 2:38 AM

$FOCL https://www.linkedin.com/posts/hst-urology_urologyminute-prostatecancer-focaltherapy-share-7474347224437547008-qplQ/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

WallStreetWoof Jun. 24 at 2:54 PM

$FOCL We lost our most prolific poster who seemed to have a pulse on the stock talking about a big investor on the west coast. Alas, can't remember the posters handle. Wonder if the poster is still around or has been banned and that is why all the posts over the last 2 years have been deleted.

1 · Reply

WallStreetWoof Jun. 24 at 2:50 PM

$FOCL Not a fake run up. Nice steady rise. Should never have dipped back in March/April...imho. Company totally focused on HIFU....will bear fruit....at least one firm has upgraded price target to $10. My price target is $15.

0 · Reply

Sonnab10 Jun. 24 at 12:31 PM

$FOCL Another fake run up?

2 · Reply

Georges8792 Jun. 24 at 2:18 AM

$FOCL https://www.linkedin.com/posts/gil-dubernard-md-phd-endometriosis-expert-surgeon-and-sonologist-196bab135_eel-hcl-hifu-ugcPost-7475264507183886336-wWnn/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

AnitaGunderson Jun. 23 at 1:40 PM

$FOCL They have had a successful Operation on Prostrate Cancer. That alone is huge.

1 · Reply

sanman20 Jun. 22 at 6:01 PM

$FOCL https://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html?classic=1

0 · Reply

WallStreetWoof Jun. 22 at 4:59 PM

$FOCL Let's break 5 dollars this week....

0 · Reply

bigshipper Jun. 22 at 2:06 PM

$FOCL MM doesn't want it over 5 and not enough volume to make him change his mind

2 · Reply

FocalTherics initiated with a Buy at Lucid Capital

Jun 16, 2026, 7:30 AM EDT - 8 days ago

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical

Jun 4, 2026, 2:00 PM EDT - 20 days ago

EDAP TMS Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 8:00 AM EDT - 23 days ago

EDAP TMS Transcript: Investor Day 2026

Jun 1, 2026, 8:00 AM EDT - 23 days ago

EDAP TMS Slides: FY 2026

May 29, 2026, 7:30 AM EDT - 26 days ago

EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy

May 21, 2026, 7:30 AM EDT - 4 weeks ago

EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference

May 14, 2026, 7:30 AM EDT - 5 weeks ago

EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer

May 13, 2026, 4:30 PM EDT - 6 weeks ago

EDAP | Focal One to Host Investor Day on June 1, 2026

May 7, 2026, 7:30 AM EDT - 6 weeks ago

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue

Apr 30, 2026, 8:30 AM EDT - 7 weeks ago

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

Apr 16, 2026, 7:30 AM EDT - 2 months ago

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

Mar 25, 2026, 7:30 AM EDT - 3 months ago

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

Mar 10, 2026, 7:30 AM EDT - 3 months ago

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 4, 2026, 7:30 AM EST - 4 months ago

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

Feb 12, 2026, 7:30 AM EST - 4 months ago

EDAP Announces Appointment of David Horn to Board of Directors

Jan 12, 2026, 7:30 AM EST - 5 months ago

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

Nov 20, 2025, 7:30 AM EST - 7 months ago

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

Nov 18, 2025, 7:00 AM EST - 7 months ago

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 6, 2025, 7:30 AM EST - 8 months ago

EDAP Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 7:00 AM EST - 8 months ago

EDAP to Present at Jefferies Global Healthcare Conference in London

Oct 27, 2025, 7:00 AM EDT - 8 months ago

EDAP to Participate in the UBS Global Healthcare Conference

Oct 23, 2025, 7:00 AM EDT - 8 months ago

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

Oct 20, 2025, 8:30 AM EDT - 8 months ago

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Sep 30, 2025, 7:00 AM EDT - 9 months ago

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Sep 16, 2025, 7:00 AM EDT - 10 months ago

Focal One® HIFU Receives Prestigious Innovation Award

Sep 8, 2025, 7:00 AM EDT - 10 months ago

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

Aug 28, 2025, 7:00 AM EDT - 10 months ago

EDAP Reports Strong Second Quarter 2025 HIFU Results

Aug 26, 2025, 7:00 AM EDT - 10 months ago

EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion

Aug 25, 2025, 7:00 AM EDT - 10 months ago

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 7, 2025, 7:00 AM EDT - 11 months ago

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

Jul 1, 2025, 7:00 AM EDT - 1 year ago

EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status

May 27, 2025, 7:00 AM EDT - 1 year ago

EDAP to Present at the Jefferies Global Healthcare Conference

May 15, 2025, 7:00 AM EDT - 1 year ago

EDAP Reports First Quarter 2025 Financial Results

May 1, 2025, 7:00 AM EDT - 1 year ago

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

Apr 29, 2025, 7:00 AM EDT - 1 year ago

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Apr 24, 2025, 7:00 AM EDT - 1 year ago

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Apr 22, 2025, 7:00 AM EDT - 1 year ago

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Mar 27, 2025, 7:10 AM EDT - 1 year ago

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Mar 6, 2025, 7:00 AM EST - 1 year ago

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

LUNG

Feb 6, 2025, 8:00 AM EST - 1 year ago

Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

Jan 13, 2025, 7:00 AM EST - 1 year ago

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Jan 10, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Joshua H. Levine to Board of Directors

Jan 8, 2025, 7:00 AM EST - 1 year ago

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Dec 4, 2024, 9:10 AM EST - 1 year ago

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

Nov 19, 2024, 8:00 AM EST - 1 year ago

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

Oct 24, 2024, 8:00 AM EDT - 1 year ago

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

Sep 19, 2024, 8:00 AM EDT - 1 year ago

EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures

Aug 29, 2024, 8:00 AM EDT - 1 year ago

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 7:00 AM EDT - 1 year ago

EDAP Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 7:00 AM EDT - 2 years ago

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

Jul 19, 2024, 4:15 PM EDT - 2 years ago

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

Jun 3, 2024, 8:00 AM EDT - 2 years ago

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

Georges8792 Jun. 25 at 2:39 AM

0 · Reply

Georges8792 Jun. 25 at 2:38 AM

0 · Reply

WallStreetWoof Jun. 24 at 2:54 PM

1 · Reply

WallStreetWoof Jun. 24 at 2:50 PM

0 · Reply

Sonnab10 Jun. 24 at 12:31 PM

$FOCL Another fake run up?

2 · Reply

Georges8792 Jun. 24 at 2:18 AM

0 · Reply

AnitaGunderson Jun. 23 at 1:40 PM

$FOCL They have had a successful Operation on Prostrate Cancer. That alone is huge.

1 · Reply

sanman20 Jun. 22 at 6:01 PM

$FOCL https://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+EDAP+TMS+S.A.+%28EDAP%29+at+Buy/26669462.html?classic=1

0 · Reply

WallStreetWoof Jun. 22 at 4:59 PM

$FOCL Let's break 5 dollars this week....

0 · Reply

bigshipper Jun. 22 at 2:06 PM

$FOCL MM doesn't want it over 5 and not enough volume to make him change his mind

2 · Reply

WallStreetWoof Jun. 18 at 6:19 PM

$FOCL Me thinks FOCL will close above $5 today. I am usually wrong. FOCL usually moves up last half of July through first half of September. FOCL has drawn down two tranches, and has one trach left; These are performance based tranches, so far so good. Company will probably have a write off for lithotripsy this quarter as company pivots to focus on HIFU.

0 · Reply

mikegrand Jun. 18 at 6:42 AM

$FOCL it’ll be interesting to see how the contract with MellingMedical turns out, they have the advantage of being a SDVOSB and also having FSS which will make sales smoother And also the Cleland-Doyle Act of 2022 requires VA clinics to purchase the latest equipment specifically when it comes to prostate cancer so this should be a massive catalyst for sales What has me worried however is that Sonablate and TULSA have already been associated with SDVOSB companies and it didn’t really move their numbers that much. Focal One does have the advantage that it is very known in both major healthcare systems and university healthcare systems and have backing from very prestigious centers and from I have heard training is not bad especially now that the Focal One i has very in depth collaboration capabilities which should streamline training

0 · Reply

Georges8792 Jun. 16 at 12:21 PM

$FOCL https://www.linkedin.com/posts/cancer-prostatecancer-urology-ugcPost-7472321757744496640-9d6n/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Georges8792 Jun. 14 at 7:01 PM

$FOCL https://www.linkedin.com/posts/rajesh-k-ahlawat-b368319b_prostatecancer-urologicalcancer-urooncology-share-7471897734644383744-M905/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

1 · Reply

mikegrand Jun. 11 at 5:29 AM

$FOCL https://www.linkedin.com/posts/saint-alphonsus-health-system_during-mens-health-month-its-an-important-activity-7470562698385059840-Cyxy?utm_medium=ios_app&rcm=ACoAABZ4a-oBRZvtgGd6GG5jPlHvFqid_NjYYwY&utm_source=social_share_send&utm_campaign=copy_link Extremely impressive averaging about one to two cases a week, I’ve seen the same average at my hospital too. I can imagine it’s the same at most hospitals right now

1 · Reply

Georges8792 Jun. 10 at 6:09 AM

$FOCL https://www.linkedin.com/posts/east-valley-urology-center-9272072aa_the-focal-one-hifu-robotic-system-ugcPost-7470231048560279552-cBqL/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Georges8792 Jun. 8 at 10:03 AM

$FOCL https://www.linkedin.com/posts/veronica-sawyer-b-s-m-p-t-9ba14ba5_prostatecancer-medtech-urology-ugcPost-7469674352687378432-O-uP/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Georges8792 Jun. 5 at 7:12 PM

$FOCL 🤩🤩🤩🤩

0 · Reply

Georges8792 Jun. 5 at 3:10 PM

$FOCL https://www.linkedin.com/posts/hst-urology_congratulations-are-in-orderanother-milestone-share-7468022508365991937-yGnk/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

MPInvest19 Jun. 5 at 3:07 PM

$FOCL Between all the publications/ readouts this year in addition to the huge topline growth the SP will explode this year. Oslo farp has been confirmed it will be published shortly (focal therapy vs radical surgery) Gil dubernard a phase II &III long term data confirmed to be coming shortly inclusive of 12 month follow up data for crossover patients HIFUSA ( hifu vs active surveillance) data presented at AFU in Paris in Nov 2025 and confirmed to be published this year. First BPH readout before year end confirmed by Ryan Rhodes. Following dubernard endo publication a formal FDA path will be established for 2nd indication for focal one in USA HIFI data already driving huge growth and with recent publication of HIFI 2 ( salvage hifu following failed radiation) it just strengthens the data set. Finally 2 highly reputable analysts from TD COWEN and Mizuho were sitting front row and asking questions during investor day. Likely to see their price targets shortly.

0 · Reply

Georges8792 Jun. 4 at 8:11 AM

$FOCL https://www.linkedin.com/posts/baus2026-roboticsurgery-medtech-ugcPost-7467992326657863680-5uKi/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Georges8792 Jun. 4 at 8:10 AM

$FOCL https://www.linkedin.com/posts/utilisation-du-focal-one-au-psr-ugcPost-7463249841721192450-sP3_/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

0 · Reply

Market Cap	183.66M
Revenue (ttm)	70.53M
Net Income (ttm)	-29.25M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-41.47%
Debt to Equity Ratio	2.41

Volume	68,400
Avg Vol	40,048
Day's Range	N/A - N/A
Shares Out	37.48M
Stochastic %K	72%
Beta	0.00
Analysts	Sell
Price Target	$5.83